ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
44
views
0
references
Top references
cited by
52
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,746
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Keynote address on biostatistics and data retrieval.
Author(s):
Charles M. Zelen
Publication date:
1973-02-28
Journal:
Cancer chemotherapy reports. Part 1
Keywords:
Antineoplastic Agents
,
administration & dosage
,
Carcinoma, Bronchogenic
,
Clinical Trials as Topic
,
Humans
,
Information Systems
,
Lung Neoplasms
,
classification
,
drug therapy
,
pathology
,
therapy
,
Methods
,
Placebos
,
Prognosis
,
Quality Control
,
Research
,
Statistics as Topic
,
Time Factors
Read this article at
ScienceOpen
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ChemSpider related publications
Author and article information
Journal
PubMed ID::
4580860
ScienceOpen disciplines:
Chemistry
Keywords:
Antineoplastic Agents
,
administration & dosage
,
Carcinoma, Bronchogenic
,
Clinical Trials as Topic
,
Humans
,
Information Systems
,
Lung Neoplasms
,
classification
,
drug therapy
,
pathology
,
therapy
,
Methods
,
Placebos
,
Prognosis
,
Quality Control
,
Research
,
Statistics as Topic
,
Time Factors
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Antineoplastic Agents
,
administration & dosage
,
Carcinoma, Bronchogenic
,
Clinical Trials as Topic
,
Humans
,
Information Systems
,
Lung Neoplasms
,
classification
,
drug therapy
,
pathology
,
therapy
,
Methods
,
Placebos
,
Prognosis
,
Quality Control
,
Research
,
Statistics as Topic
,
Time Factors
Comments
Comment on this article
Sign in to comment
Similar content
3,746
Pembrolizumab (MK-3475) versus paclitaxel as second-line therapy for advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Phase 3 KEYNOTE-061 study
Authors:
A Ohtsu
,
J TABERNERO
,
Y.-J. Bang
…
Pembrolizumab after progression on platinum and cetuximab in head and neck squamous cell carcinoma (HNSCC): results from KEYNOTE-055
Authors:
R. Haddad
,
T. Seiwert
,
D.G. Pfister
…
Primer of biostatistics
Authors:
SA Glantz
,
S.A. Glantz
See all similar
Cited by
52
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
Authors:
Corinne Faivre-Finn
,
Michael Snee
,
Linda Ashcroft
…
Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases
Authors:
B Brenner
,
M Shah
,
M Gönen
…
Multifunctional neuron-specific enolase: its role in lung diseases
Authors:
Cai-Ming Xu
,
Ya-Lan Luo
,
Shuai Li
…
See all cited by